Trials / Completed
CompletedNCT01243138
Africa and Middle East Cardiovascular Epidemiological Study
Prevalence of Cardiovascular Risk Factors in Patients Attending General Practice Clinics in Selected Countries in the Africa and The Middle East Region
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,386 (actual)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This is a cross-sectional, epidemiological study to determine the prevalence of cardiovascular risk factors such as obesity, smoking, dyslipidemia, diabetes mellitus and hypertension in patients attending General Practice clinics in the Africa and Middle East region. A total of 4300 patients will be evaluated. In patients who are found to have previously been diagnosed with cardiovascular (CV) risk factors such as dyslipidemia or hypertension, the level of control of their respective conditions will also be evaluated.
Detailed description
This is a cross-sectional, epidemiological study. In the course of this study, 4,300 persons from general practice, and other non specialist clinics of selected countries of the Africa and Middle East region, will be evaluated for the presence of cardiovascular (CV) risk factors such as obesity, smoking, dyslipidaemia, diabetes mellitus and hypertension. The degree of control of hypertension and dyslipidaemia in those previously diagnosed with these conditions will also be assessed. All medications used for CV risk factor control will also be ascertained. Patient evaluation will be done by physicians in charge of the selected clinics (who will be trained for case report forms completion) over one visit, through history taking, clinical examination as well as laboratory investigations. Every fifth patient seen on a particular day, fulfilling the inclusion and exclusion criteria would be included in the study.
Conditions
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2012-04-01
- Completion
- 2012-04-01
- First posted
- 2010-11-18
- Last updated
- 2021-02-18
Locations
73 sites across 14 countries: Algeria, Cameroon, Egypt, Ghana, Jordan, Kenya, Kuwait, Lebanon, Nigeria, Saudi Arabia, Senegal, South Africa, Tunisia, United Arab Emirates
Source: ClinicalTrials.gov record NCT01243138. Inclusion in this directory is not an endorsement.